Clinical trial Recruiting at 4 sites Interventional Ages 15 to 29

A tool to help young cancer patients manage their symptoms

Official title: A Randomized Controlled Trial Using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Run by Virginia Commonwealth University · NCT05958316 · Data updated 2026-11-12

This study is testing a new computer tool to help young cancer patients better manage their symptoms during treatment.

Quick facts

Study typeInterventional
Ages15 Years to 29 Years
SexAll
Enrollment126 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations5 sites (Kansas City, Missouri and 4 other locations)
StatusRecruiting
StartedJanuary 4, 2024
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT05958316 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents and young adults who have recently been diagnosed with cancer and are currently undergoing treatment.

Probably not a fit

Patients who are unable to complete study measures due to cognitive or physical limitations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of the Computerized Symptom Assessment Tool (C-SCAT) in improving symptom self-management among adolescents and young adults diagnosed with cancer. Participants will be randomly assigned to either receive the C-SCAT intervention or usual care while undergoing cancer treatment. The study aims to assess changes in self-efficacy and self-management behaviors related to cancer symptoms over the course of treatment. A total of 126 participants will be involved, all within the first three months of their cancer diagnosis.

Why it matters

Potential benefit: If successful, this tool could empower young cancer patients to better manage their symptoms and improve their overall quality of life during treatment.

How similar studies have gone: Previous studies have shown promise in using technology for symptom management in cancer patients, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Has received at least 1 cycle of cancer treatment and is within 6 months of receiving that first cycle of treatment
* Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles
* Reports at least 1 symptom related to cancer and/or its treatment
* Able to speak, read, and write English as required for completion of the C-SCAT and study measures

Exclusion Criteria:

\- Cognitive and/or physical inability to complete study measures.

Where it's running

  • Children's Mercy Hospital
    Kansas City, Missouri, United States
    Recruiting
  • University of Utah Huntsman Cancer Institute (HCI)
    Salt Lake City, Utah, United States
    Recruiting
  • University of Utah Primary Children's Hospital
    Salt Lake City, Utah, United States
    Recruiting
  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting
  • Seattle Children's Hospital @ University of Washington
    Seattle, Washington, United States
    Active not recruiting

Study contacts

  • Principal investigator: Ronald Elswick, PhD — Virginia Commonwealth University
  • Study coordinator: Grace Hodges
  • Email: hodgesg@vcu.edu
  • Phone: 804-828-8917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.